3 Intriguing Penny Stocks With Market Cap Up To $2B

Over the last 7 days, the United States market has risen 1.6%, contributing to a 13% increase over the past year, with earnings forecasted to grow by 18% annually. In light of these conditions, finding stocks that combine value and growth potential is key for investors looking to capitalize on market opportunities. Penny stocks, despite their somewhat outdated name, represent an intriguing area of investment; they often involve smaller or newer companies that can offer surprising value when backed by strong financials.

Underneath we present a selection of stocks filtered out by our screen.

FingerMotion (FNGR)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: FingerMotion, Inc., with a market cap of $17.89 million, operates technology-enabled platforms and services in the People's Republic of China through its subsidiaries.

Operations: The company generates revenue from its Wireless Communications Services segment, amounting to $16.32 million.

Market Cap: $17.89M

FingerMotion, Inc., with a market cap of US$17.89 million, operates technology platforms in China and is actively expanding its operations in Alberta, Canada. The company has entered into strategic agreements to develop AI inference compute campuses powered by local grid and natural gas generation. Despite generating US$16.32 million from wireless communications services, FingerMotion remains unprofitable with increasing losses over the past five years at a rate of 1.6% annually. While its debt-to-equity ratio has significantly improved from 134.2% to 29.2%, the company's share price remains highly volatile, reflecting inherent risks associated with penny stocks.

• Click here and access our complete financial health analysis report to understand the dynamics of FingerMotion.
• Review our historical performance report to gain insights into FingerMotion's track record.

Duluth Holdings (DLTH)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Duluth Holdings Inc. operates in the United States, selling casual wear, workwear, outdoor apparel, and accessories for men and women with a market cap of $149.36 million.

Operations: The company generates revenue primarily from its online retail segment, which amounts to $550.75 million.

Market Cap: $149.36M

Duluth Holdings Inc., with a market cap of US$149.36 million, has recently achieved profitability, reporting net income of US$18.36 million for Q2 2026 compared to US$1.26 million the previous year. Despite a decline in sales from US$131.72 million to US$121.39 million year-over-year, earnings per share improved significantly from USD 0.04 to USD 0.50 diluted EPS, highlighting operational improvements and cost management efforts typical within penny stocks' volatility landscape. While its short-term assets exceed both short and long-term liabilities, future earnings are forecasted to decline by an average of 47% annually over the next three years.

• Jump into the full analysis health report here for a deeper understanding of Duluth Holdings.
• Understand Duluth Holdings' earnings outlook by examining our growth report.

GoodRx Holdings (GDRX)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: GoodRx Holdings, Inc. provides consumers in the United States with tools to compare prices and save on prescription drugs, with a market cap of approximately $1.12 billion.

Operations: The company generates revenue primarily from its Healthcare Software segment, which totaled $785.23 million.

Market Cap: $1.12B

GoodRx Holdings, with a market cap of US$1.12 billion, is navigating the penny stock landscape by expanding its subscription offerings, such as the new Companion Family Plan. This initiative could enhance consumer engagement and potentially stabilize revenue streams amidst recent earnings challenges, where Q2 2026 sales slightly declined to US$200.41 million from US$203.07 million a year ago, and net income decreased to US$8.54 million from US$12.84 million. Despite lower profit margins and earnings growth issues over the past year, GoodRx's strategic moves like this plan aim to support prescription volume and patient retention for retail partners while offering competitive healthcare savings options for consumers.

• Unlock comprehensive insights into our analysis of GoodRx Holdings stock in this financial health report.
• Review our growth performance report to gain insights into GoodRx Holdings' future.

Where To Now?

• Embark on your investment journey to our 309 US Penny Stocks selection here.
• Ready To Venture Into Other Investment Styles? This technology could replace computers: discover the 24 stocks are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com